Rite Aid and Albertsons hosted a short notice, invite only, almost day long meeting with analysts last week. Based on the slides presented, it appears like an attempt to re-explain/re-spin the benefits of the two companies merging from the February 20 presentation with a lot more slides, slicker graphics and videos, and updated with the reported fourth quarter financial numbers. As we already knew, they'll be #5 in revenue and #1 by debt leverage in a competitive, low margin business.
An investigation on behalf of investors of Abaxis, Inc. (NASDAQ: ABAX) in connection with the proposed takeover was announced and NASDAQ: ABAX stockholders should contact the Shareholders Foundation.
An investigation was announced concerning whether the takeover of Coastway Bancorp, Inc. by HarborOne Bancorp, Inc is unfair to NASDAQ: CWAY stockholders.
An investigation was announced for investors, who currently hold shares of Shire plc (NASDAQ: SHPG), over the takeover of Shire plc. by Takeda Pharmaceutical Company.
An investigation was announced for investors in shares of Gramercy Property Trust (NYSE: GPT), over whether the takeover of Gramercy Property Trust by Blackstone Real Estate Partners VIII is unfair.
An investigation was announced for investors, who currently hold shares of ARMO BioSciences, Inc. (NASDAQ: ARMO),over the takeover of ARMO BioSciences, Inc. by Eli Lilly and Company for $50.00 per share is unfair to NASDAQ: ARMO stockholders.
An investigation on behalf of investors of Andeavor (NYSE: ANDV) in connection with the proposed takeover was announced and NYSE: ANDV stockholders should contact the Shareholders Foundation.
The Shareholders Foundation announces that an investor in holds shares of The Finish Line, Inc. (NASDAQ: FINL), filed a lawsuit against the takeover of The Finish Line, Inc. by JD Sports Fashion Plc for $13.50 per share.
An investigation was announced for investors, who currently hold shares of MTGE Investment Corp. (NASDAQ: MTGE), over the takeover of MTGE Investment Corp. by Annaly Capital Management, Inc.